📖 Approx. 9 min
Kanagawa Prefecture, particularly the cities of Yokohama and Kawasaki, has a high concentration of medical institutions, and with the advancement of aging, medical demand continues to increase. Against this backdrop, interest in medical M&A is growing as a means for business succession, expansion, and new market entry for medical institutions. This article delves deeply into the current state of medical M&A in Kanagawa Prefecture, focusing on market trends and demand in the Yokohama and Kawasaki areas, as well as specific points for successful M&A, from the perspective of a medical industry specialist.
Current State and Trends of Medical M&A in Kanagawa Prefecture
While the aging of physicians and the shortage of successors are becoming serious issues nationwide, Kanagawa Prefecture is no exception. Especially with the “2025 problem” approaching, when the baby boomer generation will become the late elderly, maintaining and strengthening the regional medical care provision system is an urgent task. In such circumstances, medical M&A is attracting attention as an effective means to prevent the creation of healthcare deserts due to clinic closures and to effectively utilize existing medical resources. Within Kanagawa Prefecture, there is a tendency for differences in medical needs and M&A trends between urban and suburban areas. In particular, the Yokohama and Kawasaki areas, with their high population density and excellent transportation convenience, tend to have relatively high demand from buyers seeking to acquire medical institutions.
Furthermore, recent revisions to medical fees and the promotion of reforms to physician working styles are also having a significant impact on the management strategies of medical institutions. There is a growing movement to build sustainable medical care provision systems by strengthening management foundations or introducing new specialties through M&A, addressing challenges that are difficult to manage independently. For medical corporation chairpersons and clinic directors considering business succession, or for those considering the acquisition of medical institutions, understanding the unique medical environment of Kanagawa Prefecture is essential for formulating M&A strategies.
Medical Demand and Succession Needs in the Yokohama and Kawasaki Areas
Yokohama City and Kawasaki City have particularly large populations within Kanagawa Prefecture, and their aging rates tend to be higher than the national average. Consequently, in addition to general specialties such as internal medicine, orthopedics, ophthalmology, and dermatology, there is particularly high demand for home-visit care, rehabilitation, and chronic care services tailored to the elderly. Moreover, with the increase in dual-income households, there is a persistent need for medical institutions that can handle pediatrics, obstetrics and gynecology, and offer services during nighttime and holiday hours.
In the M&A market, clinics located with good access from stations, those with specific specialties, and medical institutions maintaining a stable patient base tend to attract strong interest from buyers. In particular, clinics with established patient bases and regional trust are factors that tend to lead to high valuations. However, in highly competitive areas, differentiated medical services and efficient management systems may be required. While it is difficult to provide a single figure for M&A market prices, as they vary greatly depending on various factors such as location, specialty, patient numbers, profitability, condition of medical equipment, and staffing, it is important to evaluate these factors comprehensively.
Types of Medical Corporations and Selection of M&A Schemes
When considering M&A for medical corporations, understanding their corporate type is extremely important. Medical corporations are broadly classified into “medical corporations with equity” and “medical corporations without equity (including those funded by contributions).” The M&A schemes, procedures, and tax treatments differ significantly depending on each type.
[Comparison of Medical Corporation Types and M&A Schemes]
| Item | Medical Corporation with Equity | Medical Corporation without Equity (Including Contribution-Based) | Individual Clinic |
|---|---|---|---|
| Corporate Form | Social Medical Corporation (Old System) | Social Medical Corporation (New System), Foundation Medical Corporation | Sole Proprietorship |
| Examples of M&A Schemes |
|
|
|
| Main Considerations |
|
|
|
In the case of medical corporations with equity, it is common to change members by purchasing their equity, but the valuation of this equity often becomes an issue. On the other hand, for medical corporations without equity, the provisions for returning contributions can affect M&A. For individual clinics, business transfers, often accompanied by incorporation into a medical corporation, or simple business transfers are the main options, and the succession procedures for the clinic license and designation as a medical institution are important. In any type, selecting the optimal scheme based on the M&A objectives, the assets and liabilities involved, and the intentions of the stakeholders is the key to success.
Specific Legal and Tax Issues in Medical M&A to Consider
Medical institution M&A involves highly specialized legal regulations such as the Medical Care Act, the Physician Act, and the Pharmaceutical and Medical Device Act, which differ from typical corporate M&A. Therefore, it is necessary to have a deep understanding of the legal and tax issues involved.
[Important Checkpoints in Medical M&A]
- Succession of Licenses and Permits: Medical institution licenses and designations as medical institutions are generally tied to the corporate entity or the individual establishing physician. Depending on the M&A scheme, new acquisition may be necessary. A smooth succession plan is essential.
- Change of Members/Directors: Changes in the members or directors of a medical corporation require notification and approval from the competent authorities. In particular, the approval processes of the general meeting of members and the board of directors must be strictly adhered to.
- Succession of Medical Fees: It is necessary to confirm whether the facility standards and staffing requirements that serve as the basis for calculating medical fees can be maintained after the M&A, and whether any new ones need to be acquired.
- Treatment of Business Tax: In the case of business transfers of individual clinics, business tax may be levied on the capital gains from the transfer of business assets. This differs from the transfer of corporate shares, so caution is required.
- Capital Gains Tax: When an individual proprietor transfers their business, it is subject to comprehensive or separate taxation as capital gains. In the case of transferring shares of a medical corporation, it is generally subject to separate taxation, and the tax rate differs.
- Compatibility with Regional Medical Care Plans: Particularly for medical institutions with beds, consideration must be given to consistency with bed reorganization plans under regional medical care plans.
- Medical Liabilities and Medical Accident Risks: Potential risks related to past medical liabilities and medical accidents must be thoroughly identified through due diligence.
These issues affect various stages of the M&A process, from negotiation and closing to post-M&A management. Obtaining appropriate advice from experts and steadily resolving each issue is essential to avoid unexpected troubles and achieve a smooth M&A.
Impact of Medical Fee Revisions and Facility Standards on M&A
The revenue structure of medical institutions is heavily dependent on the medical fee system. Therefore, the medical fee revisions conducted every two years directly impact the evaluation of the future profitability of medical institutions targeted for M&A. For example, revisions to the fees for specific medical procedures or facility standards may necessitate significant adjustments to post-M&A management plans.
When considering M&A, it is important to analyze the details of the most recent medical fee revisions and evaluate whether the fees and facility standards currently claimed by the target medical institution can be maintained in the future, or if there is room for further development. Furthermore, if considering new facility standards, conversion to a community-based integrated care ward, or transition to a DPC (Diagnosis Procedure Combination) hospital as part of post-M&A management strategy, the feasibility and investment recovery period must be carefully assessed. In particular, as the differentiation and collaboration of bed functions accelerate with the progress of regional medical care plans, the vision for contributing to regional healthcare through M&A and ensuring its consistency can also be a factor influencing the success or failure of the M&A.
M&A Valuation and Due Diligence Points
Similar to general business valuations, M&A valuations for medical institutions often employ methods such as DCF (Discounted Cash Flow), comparable company analysis, and net asset valuation. However, it is necessary to consider factors specific to medical institutions. Specifically, stable patient numbers, repeat visit rates, the presence of specialists, the depreciation status of medical equipment, regional brand strength, and the quality and retention rate of medical personnel significantly influence the valuation.
Particularly important is due diligence (fair assessment procedure) to thoroughly investigate the medical institution targeted for M&A. Due diligence in medical M&A, in addition to general financial, legal, and labor due diligence, requires a thorough identification of medical-specific risks, including compliance with medical regulations, appropriateness of medical fee claims, history of medical accidents, personal information protection systems, and compatibility of IT systems (electronic health records, etc.).
- Financial Due Diligence: Analyze past income statements, balance sheets, and cash flow statements to assess profitability, growth potential, and financial health. In particular, confirm medical fee claim records and the status of accounts receivable.
- Legal Due Diligence: Confirm compliance with laws such as the Medical Care Act, Physician Act, and Pharmaceutical and Medical Device Act, the status of licenses and permits, the presence or absence of medical lawsuits or administrative penalties, and contractual relationships (leases, equipment leases, etc.).
- Labor Due Diligence: Investigate employment contracts for physicians, nurses, and paramedical staff, work rules, risks of unpaid overtime wages, social insurance enrollment status, and turnover rates.
- Medical Due Diligence: Evaluate medical treatment records, patient trends, maintenance status of medical equipment, compliance with facility standards, medical safety management systems, and infection control measures.
- IT Due Diligence: Confirm the compatibility of the electronic health record system, security measures, and the possibility of data migration.
Through this due diligence, identifying potential risks and contingent liabilities and reflecting them in the M&A terms negotiation is essential for the buyer to minimize post-acquisition risks and for the seller to obtain a fair valuation.
Successful M&A Strategy and the Importance of Utilizing Experts
To achieve successful medical M&A, a clear strategy and the utilization of experts are indispensable. First, it is important to clarify the objectives of the M&A. The optimal form of M&A varies depending on the purpose, such as business succession, expansion, new market entry, or contribution to regional healthcare. Based on the characteristics of the Yokohama and Kawasaki areas, defining which type of medical institution to target and what kind of synergistic effects to expect is the first step in M&A strategy.
Next, it is crucial to select a reliable M&A intermediary or advisor. Medical M&A requires specialized knowledge and experience different from general corporate M&A, so it is desirable to choose experts specializing in the medical industry. They provide professional support at all stages of the M&A process, including matching with appropriate parties, business valuation, due diligence support, negotiation strategy development, contract drafting, and administrative procedures. Collaboration with experts in each field, such as lawyers, certified public accountants, and tax accountants, is also essential to resolve complex legal and tax issues.
M&A is not merely a transaction of buying and selling; it is a management strategy that influences the future of a medical institution. Those considering medical M&A in Kanagawa Prefecture, particularly in the Yokohama and Kawasaki areas, are encouraged to consult with experts. At M&A Medical, consultants well-versed in the medical industry will propose the optimal M&A strategy tailored to your institution’s situation and preferences, and provide comprehensive support for success.
Consultations on Medical Succession to M&A Medical
M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support organization certified by the Small and Medium Enterprise Agency, we support the success of transfers of clinics and medical corporations struggling with a lack of successors, as well as strategic acquisitions, on a success fee basis.
- Initial consultation and preliminary appraisal are free
- No upfront fees or monthly charges (only success fees)
- Strict confidentiality (proceeds after NDA signing)
- Support for all 47 prefectures and all medical specialties
Please consult with us early, even in the initial stages of consideration, whether you just want to know the market price, have no successor, or are considering joining a group.